Secretary's Advisory Committee on Heritable Disorders in Newborns and Children; Notice of Meeting, 17140 [2011-7166]

Download as PDF 17140 Federal Register / Vol. 76, No. 59 / Monday, March 28, 2011 / Notices out of an electronic medical record, and the purchase and use of a mobile medical van. SPHC is an experienced provider of care and has a demonstrated record of compliance with Health Center Program statutory and regulatory requirements and is located in the same geographical area. The transfer of the ARRA Capital Improvement Project funds will ensure that critical primary health care services continue and remain available to the low-income, underserved homeless patients with no interruption in services to the target population. FOR FURTHER INFORMATION CONTACT: Marquita Cullom-Scott via e-mail at MCullom-Scott@hrsa.gov or 301–594– 4300. Dated: March 23, 2011. Mary K. Wakefield, Administrator. [FR Doc. 2011–7248 Filed 3–25–11; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children; Notice of Meeting Emcdonald on DSK2BSOYB1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children. Dates and Times: May 5, 2011, 9:30 a.m. to 5 p.m., May 6, 2011, 8:30 a.m. to 3:30 p.m. Place: Renaissance Washington, DC, Dupont Circle Hotel, 1143 New Hampshire Avenue, NW., Washington, DC 20037. Status: The meeting will be open to the public with attendance limited to space availability. Participants are asked to register for the meeting by going to the registration Web site at http://altarum.cvent.com/event/ SACHDNC052011. The registration deadline is Tuesday, May 3, 2011. Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations should indicate their needs on the registration Web site. The deadline for special accommodation requests is Friday, April 29, 2011. If there are technical problems gaining access to the Web site, please contact Maureen Ball, Meetings Coordinator at conferences@altarum.org. Purpose: The Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children (Advisory Committee) was established to advise and guide the Secretary regarding the most appropriate application of universal newborn VerDate Mar<15>2010 17:14 Mar 25, 2011 Jkt 223001 screening tests, technologies, policies, guidelines and programs for effectively reducing morbidity and mortality in newborns and children having or at risk for heritable disorders. The Advisory Committee as authorized under the Public Health Service Act 42 U.S.C. 300b–10, and amended in the Newborn Screening Saves Lives Act of 2008, also provides advice and recommendations concerning the grants and projects authorized under the Public Health Service Act, 42 U.S.C. 300b–8, (Heritable Disorders Program) as amended in the Newborn Screening Saves Lives Act of 2008. Agenda: The meeting will include: (1) A presentation of the External Review Workgroup’s final report on the nomination of Hyperbilirubinemia to the Advisory Committee’s recommended uniform screening panel; (2) an update from the Evidence Evaluation Methods workgroup; and (3) presentations on the continued work and reports of the Advisory Committee’s subcommittees on laboratory standards and procedures, follow-up and treatment, and education and training. Proposed agenda items are subject to change as priorities dictate. You can locate the Agenda, Committee Roster and Charter, presentations, and meeting materials at the home page of the Advisory Committee’s Web site at http:// www.hrsa.gov/heritabledisorderscommittee/. Public Comments: Members of the public can submit written comments and/or present oral comments during the public comment periods of the meeting, which are scheduled for both days of the meeting. Those individuals who want to make oral comments are requested to register online by Tuesday, May 3, 2011 at http:// altarum.cvent.com/event/SACHDNC052011. Requests should contain the name, address, telephone number, and any professional or business affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. Written comments should be emailed no later than Tuesday, May 3, 2011, for consideration. Written comments should contain the name, address, telephone number, and any professional or business affiliation of the author. Submit written comments to Maureen Ball, Meetings Coordinator, Conference and Meetings Management, Altarum Institute, 1200 18th Street, NW., Suite 700, Washington, DC 20036, telephone: 202 828–5100; fax: 202 785–3083, or e-mail: conferences@altarum.org. Contact Person: Anyone interested in obtaining other relevant information should write or contact Alaina M. Harris, Maternal and Child Health Bureau, Health Resources and Services Administration, Room 18A–19, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857, Telephone (301) 443–0721, aharris@hrsa.gov. More information on the Advisory Committee is available at http://mchb.hrsa.gov/ heritabledisorderscommittee. DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: March 22, 2011. Wendy Ponton, Director, Office of Management. National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting [FR Doc. 2011–7166 Filed 3–25–11; 8:45 am] Pursuant to section 10(d) of the Federal Advisory Committee Act, as BILLING CODE 4165–15–P PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 National Institutes of Health National Center for Complementary & Alternative Medicine; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; Neurophysiological and Pain Management with CAM Treatments. Date: April 5, 2011. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call) Contact Person: Hungyi Shau, PhD, Scientific Review Officer, National Center for Complementary and Alternative Medicine, National Institutes of Health, 6707 Democracy Boulevard, Suite 401, Bethesda, MD 20892, 301–402–1030, Hungyi.Shau@nih.gov. This meeting is being published less than 15 days prior to the meeting date due to scheduling conflicts. (Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training in Complementary and Alternative Medicine, National Institutes of Health, HHS) Dated: March 21, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–7199 Filed 3–25–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health E:\FR\FM\28MRN1.SGM 28MRN1

Agencies

[Federal Register Volume 76, Number 59 (Monday, March 28, 2011)]
[Notices]
[Page 17140]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-7166]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Secretary's Advisory Committee on Heritable Disorders in Newborns 
and Children; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:

    Name: Secretary's Advisory Committee on Heritable Disorders in 
Newborns and Children.
    Dates and Times: May 5, 2011, 9:30 a.m. to 5 p.m., May 6, 2011, 
8:30 a.m. to 3:30 p.m.
    Place: Renaissance Washington, DC, Dupont Circle Hotel, 1143 New 
Hampshire Avenue, NW., Washington, DC 20037.
    Status: The meeting will be open to the public with attendance 
limited to space availability. Participants are asked to register 
for the meeting by going to the registration Web site at http://altarum.cvent.com/event/SACHDNC052011. The registration deadline is 
Tuesday, May 3, 2011. Individuals who need special assistance, such 
as sign language interpretation or other reasonable accommodations 
should indicate their needs on the registration Web site. The 
deadline for special accommodation requests is Friday, April 29, 
2011. If there are technical problems gaining access to the Web 
site, please contact Maureen Ball, Meetings Coordinator at 
conferences@altarum.org.
    Purpose: The Secretary's Advisory Committee on Heritable 
Disorders in Newborns and Children (Advisory Committee) was 
established to advise and guide the Secretary regarding the most 
appropriate application of universal newborn screening tests, 
technologies, policies, guidelines and programs for effectively 
reducing morbidity and mortality in newborns and children having or 
at risk for heritable disorders. The Advisory Committee as 
authorized under the Public Health Service Act 42 U.S.C. 300b-10, 
and amended in the Newborn Screening Saves Lives Act of 2008, also 
provides advice and recommendations concerning the grants and 
projects authorized under the Public Health Service Act, 42 U.S.C. 
300b-8, (Heritable Disorders Program) as amended in the Newborn 
Screening Saves Lives Act of 2008.
    Agenda: The meeting will include: (1) A presentation of the 
External Review Workgroup's final report on the nomination of 
Hyperbilirubinemia to the Advisory Committee's recommended uniform 
screening panel; (2) an update from the Evidence Evaluation Methods 
workgroup; and (3) presentations on the continued work and reports 
of the Advisory Committee's subcommittees on laboratory standards 
and procedures, follow-up and treatment, and education and training. 
Proposed agenda items are subject to change as priorities dictate. 
You can locate the Agenda, Committee Roster and Charter, 
presentations, and meeting materials at the home page of the 
Advisory Committee's Web site at http://www.hrsa.gov/heritabledisorderscommittee/.
    Public Comments: Members of the public can submit written 
comments and/or present oral comments during the public comment 
periods of the meeting, which are scheduled for both days of the 
meeting. Those individuals who want to make oral comments are 
requested to register online by Tuesday, May 3, 2011 at http://altarum.cvent.com/event/SACHDNC052011. Requests should contain the 
name, address, telephone number, and any professional or business 
affiliation of the person desiring to make an oral presentation. 
Groups having similar interests are requested to combine their 
comments and present them through a single representative. Written 
comments should be emailed no later than Tuesday, May 3, 2011, for 
consideration. Written comments should contain the name, address, 
telephone number, and any professional or business affiliation of 
the author. Submit written comments to Maureen Ball, Meetings 
Coordinator, Conference and Meetings Management, Altarum Institute, 
1200 18th Street, NW., Suite 700, Washington, DC 20036, telephone: 
202 828-5100; fax: 202 785-3083, or e-mail: conferences@altarum.org.
    Contact Person: Anyone interested in obtaining other relevant 
information should write or contact Alaina M. Harris, Maternal and 
Child Health Bureau, Health Resources and Services Administration, 
Room 18A-19, Parklawn Building, 5600 Fishers Lane, Rockville, 
Maryland 20857, Telephone (301) 443-0721, aharris@hrsa.gov. More 
information on the Advisory Committee is available at http://mchb.hrsa.gov/heritabledisorderscommittee.

    Dated: March 22, 2011.
Wendy Ponton,
Director, Office of Management.
[FR Doc. 2011-7166 Filed 3-25-11; 8:45 am]
BILLING CODE 4165-15-P